Retraction: Novel piperazine core compound induces death in human liver cancer cells: possible pharmacological properties

Scientific Reports 6: Article number: 24172; published online: 13 April 2016; updated: 22 June 2016 This Article has been retracted by the Editors and Publishers of Scientific Reports. Following online criticisms of the published paper, an investigation at the journal has confirmed the manipulation and duplication of data and a level of image processing that is not compliant with the journal’s policies on image data integrity in figures 1–3, 6, 7, 10 and 12.

. PCC displayed a high inhibitory effect towards both cancer cells after 24 h. The IC 50 of PCC was 6.98 ± 0.11 μg/ml and 7.76 ± 0.45 μg/ml against SNU-475 and SNU-423, respectively, as compared with the standard (1.14 ± 0.02 μg/ml), while the IC 50 for PCC in normal liver cells, normal monocyte/macrophage cells and B lymphocyte was calculated as 48.63 ± 0.12 μg/ml, 53.12 ± 0.08 μg/ml and 50.35 ± 0.86 μg/ml respectively. PCC induced G1 cell cycle arrest. Development of cancer is due to dysfunction in the regulation of the cell cycle that appears in over-proliferation of cells, although cancer progression can be strongly limited by conquest of the cell cycle. Hence, the effect of 6.25 μg/ml PCC on cell cycle arrest was investigated. The BrdU and phospho-histone H3 staining of SNU-475 and SNU-423 cells treated with PCC showed that cell cycle arrest at the S/M phases did not occur (Fig. 1). However, cellular arrest in the G1 phase was detected by using flow cytometry (Fig. 2). PCC enhanced cytochrome c release and membrane permeability but reduced mitochondrial membrane potential. Because of the cytotoxic effect of PCC on SNU-475 and SNU-423 cells, permeability of the membrane was higher than in the control suggesting sustained apoptotic activity in these cells (Fig. 3A,B). Loss of mitochondrial membrane potential (MMP) was evidenced as a conceivable mechanism for cell death using MMP dye. The cytoplasm of control cells was stained more intensely than the cells treated with PCC (Fig. 3A). Both SNU-475 and SNU-423 cells treated with PCC for 24 h exhibited a dose-dependent reduction of MMP fluorescence intensity, as a result of collapsed MMP (Fig. 3A,B). The fluorescence intensity in the cytosol of SNU-475 and SNU-423 cells treated with PCC was less than control cells suggesting the release of mitochondrial cytochrome c (Fig. 3B).
PCC induced cytoskeletal rearrangement and nuclear fragmentation.  cells treated with PCC were examined for cytoskeletal and nuclear morphological alteration by phalloidin and Hoechst 33342 staining. F-actin was stained at the peripheral membrane evidencing the cell shrinkage (Fig. 4). In addition, nuclear fragmentation and condensation were indicated at the concentrations of 6.25 μg/ml of PCC in 24 h (Fig. 5). Additionally, apoptotic chromatin changes increased nuclear intensity suggesting induction of apoptosis by PCC in these cells. of propidium iodine to denatured DNA was identified by reddish-orange color after 72 h indicating the late stage of apoptosis (Fig. 6).
Detection of apoptosis. Cells were pre-treated with cell membrane permeable calcium chelator EGTA/AM (25 μM) for 1 hour followed by addition of NTC (6.0 μM) for 24 hours. Cells were stained with Annexin V FITC and PI then subjected to flow cytometry analysis. Our data indicates that apoptosis induction by NTC occurred even in the presence of the calcium chelator (Fig. 7). This finding suggests that NTC initiates caspase 8 activation and apoptosis independent from calcium signaling.
PCC enhanced reactive oxygen species production. Following treatment of SNU-475, and SNU-423 cells by PCC for 24 h, ROS production was detected by staining the live cells with DHE. Following rapid oxidation of DHE and production of DCF by ROS, the fluorescence intensity in the cells was quantified by Radiance    cells. In this method, 84 human genes involved in oxidative stress and antioxidant defence, the antioxidant peroxiredoxin (PRDX) family and redox control were examined. Results showed that the anti-oxidant related and oxidative stress genes were differentially expressed in the cells in response to PCC. Interestingly, glutathione reductase was noticeably up-regulated by more than 80 fold in SNU-423 and more than 100 fold in SNU-475 as compared with normal cells (P < 0.05). These findings were validated by qPCR.   Evaluation of acute toxicity. SD female rats were treated with a single dose of PCC (200 mg/ kg). All animals survived the treatment period after 14 days. No physical or abnormal changes was observed in the mucus membrane, eyes, skin, fur, salivation, tremors, behaviour and sleep patterns. Biochemical analysis of liver and Figure 9. Cytotoxic evaluation of PCC using lactate dehydrogenase (LDH) assay. Bar charts show that PCC was significantly able to elevate the release of LDH at the concentration of 6.25 μg/ml. All data are expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.

Figure 10. Translocation of NF-ƙB.
After treatment of both cancer cells by several concentrations of PCC for duration of 3 h, the cells were exposed for 30 min to TNF-α (1 ng/ml). Results disclosed no significant cytoplasmic to nucleus translocation of NF-kB. All data are expressed as the means ± standard error of triplicate measurements. *P < 0.05 compared with the no-treatment group.
Scientific RepoRts | 6:24172 | DOI: 10.1038/srep24172 kidney were reported normal ( Table 2). No differences were observed in kidney and liver tissue histopathology analysis of PCC-treated rats compared to the normal control group (Fig. 13).

Discussion
The ability of malignant cells to evade apoptosis is a hallmark of cancer. Thus, a comprehensive understanding of apoptotic signaling pathways is mandatory for discovery of target selective therapeutic drugs. Through investigation of the properties of PCC as a new derivative of piperazine in the current study, we found that this agent is potentially cytotoxic against liver cancer cells. In particular, PCC can simultaneously induce both extrinsic and intrinsic apoptotic signaling pathways in these cells. PCC showed a selective activity against cancer cells with no effect on normal cells. This feature can be considered as a prominent property of this compound in cancer treatment. Our findings provide molecular evidence for potential cytotoxic properties of PCC in the liver cancer cells by its stimulation of both extrinsic and intrinsic apoptotic signaling pathways. Apoptosis consists of morphological and biochemical changes. Following a death signal, morphological events initiated by cell shrinkage and chromatin condensation proceed to membrane blebbing and nuclear fragmentation and finally end with apoptotic body formation. To address whether PCC induces cytological alterations in the liver cancer cell lines, we monitored the cell membrane, LDH and cytochrome c release, ROS production, mitochondrial membrane potential, cytoskeleton, nuclear fragmentation and NF-κ B translocation in PCC treated cells. Results showed that PCC can stimulate cytoskeletal shrinkage-related reorganization. This compound substantially damages membrane integrity at a concentration of 6.25 μg/ml, leading to LDH release from the cells as a marker of cytotoxicity (Fig. 9). Analysis of membrane blebbing and chromatin condensation by using AO/PI staining revealed the morphological changes relevant to the apoptotic event (Fig 5 and 6) 17 . By increasing the period of the cell exposure to PCC from 24 to 72 h, modifications of the early to the late stage of apoptotic events appeared, suggesting that prolonged treatment of cancer cells with PCC can activate necrosis in these cells [18][19][20] . Cell cycle distribution was furthered investigated to support the occurrence of apoptosis in the cancer cells through BrdU and Phospho-Histone H3 staining 18,20 . However, neither BrdU attachment nor H3 staining in the mitotic stage was identified, indicating that there was no significant difference in the number of cells in the S/M phases. Based on flow cytometric analysis, the cells were observed to be arrested at the G1 or G2 phases. This finding confirms that cell death is triggered by apoptosis 21,22 . Mitochondria are the main source of ROS which regulate survival or death of cells. Our data show an extensive enhancement in the ROS levels in the PCC (6.25 μg/ml) treated cells. PCC stimulates ROS production through upregulation of GR. The enzyme, GR, as an oxidative stress indicator, plays an important role in the suppression of reactive oxygen species and in antioxidant function. Enhanced ROS production by PCC could stimulate de novo synthesis of GR 23 .
Disproportionate ROS production diminishes mitochondrial membrane potential leading to cytochrome c release from mitochondria into the cytoplasm. An increased mitochondrial cytochrome c level in the cytoplasm is a key initiative signal for induction of the intrinsic apoptosis pathway by PCC (Fig. 3A) 24,25 . Thus, PCC can be seen as a potential inducer of morphological modifications downstream of apoptotic molecular events in the liver cancer cells associated with its cytotoxic potential.
Piperazines (1, 4-diazacyclohexane) are an extensive group of chemical compounds, containing a core functional group with important pharmacological properties. They consist of a six-membered ring containing two nitrogen atoms at opposite positions in the ring. A large number of piperazine compounds have anthelmintic action. They are usually used as anti-helmintic against common roundworms such as ascariasis and pinworms (enterobiasis; oxyuriasis). Their mode of action is generally by paralysing parasites, which allows the host body to easily remove or expel the invading organ 26 . Based on the literature, unsubstituted piperazine do not show anti-cancer effect however, but when they are incorporated into to another molecule or are used as a derivate, some of them tend to show anti-cancer activity based on the compound's structure. PCC is a piperazine derivate which has potential cytotoxic effect toward liver cancer cell lines. Nevertheless, there is little data showing that piperazine compounds can induce apoptosis pathways associated with their cytotoxic properties. Recent studies have demonstrated the cytotoxic effect of some piperazine derivatives such as β -elemene piperazine, 1,4-bis-(4-(1H-benzo[d]imidazol-2-yl-phenyl) piperazine and chloroalkyl piperazine and 6-(4-substituted piperazine-1-yl)-9-(β -D-ribofuranosyl) purine in cancer cells. However, only the extrinsic pathway of apoptosis is activated by these compounds [27][28][29][30][31] whereas, PCC simultaneously activates both intrinsic and extrinsic pathways of apoptosis. To further support the role of PCC as a novel piperazine derivative with pro-apoptotic properties, we analyzed the apoptotic pathways in the liver cancer cell lines. Results showed that PCC enhanced the release of mitochondrial cytochrome c which activated caspase 9 by 4.8-5.0 fold in both liver cancer cells 32 . Interestingly, activated caspase-8 is also increased by about 5.0 fold in both cancer cell lines, suggesting that PCC-induced apoptosis is mediated by more than one pathway. Following cell excitation, calcium ions are released from mitochondria to regulate several cellular processes such as apoptosis. Therefore, prolonged elevation of cytosolic calcium ions causes cell death 33 . In addition, mitochondrial calcium ion uptake alters the mitochondrial permeability which switches on the apoptosis event in response to the stress. Increase of calcium ion levels occurs at both the early and late stages of apoptosis. Hence, intracellular calcium ion elevation causes cell death through apoptosis pathways [34][35][36] . On the basis of the absence of cytosolic free calcium evaluated by using a calcium chelator (EGTA/AM) and flow cytometry analysis of Annexin-V in the PCC treated cells, an increase in the number of cells was detected (Fig. 7). Therefore, caspase 8 has been activated by PCC independent of intracellular calcium concentrations.
In liver cancer, development of resistance against various therapeutic interventions, such as chemotherapy has been linked to the expression of Bcl-2 and Bcl-xL [37][38][39] . Bcl-2 is an anti-apoptotic mediator that is expressed in different cancer types and serves as a checkpoint in execution of the caspase cascade and mitochondrial dysfunction 24,25,40 . Vis-à-vis, Bcl-xL blocks cell death through regulation of mitochondrial homeostasis 25,32 . Furthermore, the tumor suppressor P53, an apoptosis mediator in numerous cells, activates by DNA damage and triggers apoptosis to eliminate permanently damaged cells 41 . Dysfunction or down-regulation of p53 may induce tumor progression and resistance to chemotherapy 42 . Our experimental data show that PCC reduces the levels of Bcl-2 and Bcl-xL, but increases p53 concentration in the PCC-treated liver cancer cells. Cytotoxic drugs can mediate cleavage of Bid through activation of caspase 8 37,38 . In the absence of interaction between ligand and death domain adaptor protein, some drugs may activate caspase-8 39 . Following the conversion of Bid to its truncated form (tBid), mitochondrial cytochrome c is released into the cytoplasm to activate Bax 43 . In this study, the process of cell death was associated with upregulation of Bax and caspase-8/Bid pathway in PCC treated cells 44,45 . In addition, we showed that the anticancer potential of PCC is via blocking the NF-κ B signaling pathways. Targeting NF-κ B signaling pathway by drugs has been considered as novel chemotherapeutic objectives in cancer therapy 25,46,47 . Evidence showed a linkage between anticancer drug resistance and enhanced activity of the NF-κ B pathway 46 . NF-κ B antagonists inhibit binding of this molecule to DNA resulting in suppression of cell proliferation. There are numerous NF-κ B inhibitors available in the market that inhibit the translocation of NF-κ B to the nucleus. Based on our results, PCC can be considered as antagonist/inhibitor of the NF-κ B pathway because PCC    inhibits nuclear translocation of NF-κ B, resulting in cell death. Hence, we conclude that other NF-κ B inhibitors may not have any influence on the biological effect of PCC, though they could act in synergy with PCC. In summary, among all mechanisms found in this study, simultaneous initiation of the intrinsic and extrinsic pathways of apoptosis via series of caspase activity, cell cycle arrest, down-regulation of Bcl-2 and Bcl-xL, up-regulation of p53 and Bax and inhibiting the NF-κ B pathway are the most critical effects of PCC on liver cancer cells.

Conclusion
Evaluation of the cytotoxic properties of PCC in the current study suggests that this compound has potential as an anticancer agent against liver cancer cells. PCC simultaneously induces both intrinsic and extrinsic apoptosis pathways, and hence, can be nominated as a potential anti-cancer agent for future in vivo studies.
Deprotection of the carbamate was achieved using 20% HCl in methanol. Subsequent amidation using triethylamine and various acyl chlorides yielded the final compounds that were tested after purification and structure validation using NMR  Figure 2A,B).
Purification procedure. The spectrophotometric analysis for PCC in hydrochloric acid (0.01 mol/l) was performed using a UV/VIS Lambda 20 (Perkin Elmer) spectrophotometer (Supplementary Figure 3). The specific absorption coefficient and the molar absorbency index for PCC were calculated based on the Lambert-Beer equation (Table 3). The solutions of PCC were prepared over a concentration range from 0.00098% to 0.00141%. The course of hydrolysis in an acidic medium (at HCl 0.1 mole/l, pH = 1.11 and 60 °C) was followed by the TLC method using plastic sheets 20 × 20 cm with silica gel (0.   Cell viability assay. The MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide] assay was carried out to evaluate the anti-proliferative activity of PCC. PCC was originally synthesized as a novel compound by Chemistry and Chemical Engineering Research Centre of Iran (CCERCI, Tehran, Iran) and donated to conduct this study. Briefly, cells were seeded 24 h prior to treatment in a 96-well plate at 7 × 10 4 cells/ml. PCC and 5-fluoruracil (standard) were dissolved in DMSO (Sigma Chemical Co., St. Louis, Missouri, USA). After incubation of the plate for 24, 48 and 72 h at 37 °C with 5% CO 2 , 50 μl of MTT solution (2 mg/ml; Sigma) was added to each well. The plates were then incubated for 24 h under the same conditions. To dissolve the purple formazan crystals, 200 μl DMSO was added to each well and incubated for 20 min. Absorbance was subsequently read at 570 nm using a spectrophotometric plate reader (Hidex, Turku, Finland). Experimental data were derived from three independent experiments. The selectivity index was obtained by mean IC50 THLE-3/mean IC50 of SNU-475 or SNU-423.
Immunofluorescence. After 24 h PCC treatment of both cancer and normal cells, 10 μg/ml JC-1 mitochondrial membrane potential dye (eBioscience, San Diego, CA) were added to the live cells followed by incubation for 30 min at 37 °C. Cells were then fixed in 4% paraformaldehyde, permeabilized by 0.25% Triton X-100, quenched with 50 mM ammonium chloride and blocked with 5% BSA in PBS overnight, followed by probing Determination of antioxidant potential. Organisms have complex antioxidant systems to protect themselves from oxidative stress; however, excessive oxidative stress can overwhelm the system and cause severe damage. To measure the antioxidant protection potential of PCC over time, the ORAC assay was used. In a black 96-well plate, 6.25 μg/ml of PCC, blank (solvent/PBS) and standard (5-fluouracil) were added to cells supplemented with fluorescein solution (150 μl) and incubated at 37 °C for 5 min. AAPH (25 μl) was then added and fluorescence intensity was assessed at 485 nm (excitation wavelength) and 538 nm (emission wavelength) every 2 min for duration of 2 h. Quantification was carried out by calculating the differences of area under the fluorescence decay curve of the samples and blank.
Detection of ROS production. ROS is produced as byproducts during mitochondrial electron transport and has potential to cause apoptosis. Intracellular reactive oxygen species were measured by using 10 mM dihydroethidium (DHE) stock solution (in methanol) diluted 500-fold in HBSS without serum or other additives to yield a 20 mM working solution. Evaluation of NF-ƙB translocation. Nuclear factor kappa-light-chain-enhancer of activated B cells controls transcription of DNA and is involved in cellular responses to stimuli such as stress, free radicals and chemicals. Cells were treated with (6.25 μg/ml) and stimulated with TNF-α . The Cellomics nuclear factor-ƙB (NF-ƙB) activation kit (Thermo Scientific) was used for staining of the cells. The average intensity ratio (200 cells/well) of the nuclear and cytoplasmic NF-ƙB was measured using cytoplasm to nucleus translocation bio-application software (S50-5001-1, Thermo Scientific). Evaluation of mitochondrial and extrinsic apoptotic pathways. Caspases are a family of cysteine proteases that have critical roles in apoptosis. Caspase 9 is involved in the intrinsic, whereas. Caspase 8 is involved in the extrinsic pathway of apoptosis. Caspase 3 interacts with caspase 8 and 9 and plays a central role in the execution phase of the cell apoptosis. Time-dependent evaluation of caspase 3/7, 8 and 9 activities in the presence of PCC (6.25 μg/ml) were performed using assay kits, Caspase-Glo 3/7, 8 and 9 (Promega Corp., Madison. WI, USA) in triplicates on white 96-well plates after 6, 12, 18, 24 and 30 h. Treatment with PCC (6.25 μg/ml) was carried out on a total of 10,000 cells per well and 100 ml of the Caspase-Glo reagent added and incubated at room temperature for 30 min. Cleavage of the aminoluciferin-labeled synthetic tetrapeptide based on the caspase activation, causes apoptotic cells to release the substrate of luciferase enzyme. Activity of caspase was evaluated using Tecan Infinite 200 Pro (Tecan, Mannedorf, Switzerland) microplate reader.

Molecular identification of apoptotic proteins induced by PCC.
Apoptotic proteins have a central role in regulation of programmed cell death via inducing (pro-apoptotic) or inhibiting (anti-apoptotic) apoptosis. 1 × 10 6 cells/ml were treated with PCC and standard (5-fluorouracil) separately for 24 h. Cells were then aspirated, lysed and resolved on 10% SDS-polyacrylamide gels followed by transferring of the proteins to PVDF membranes (Milipore) and blocking with 5% nonfat dry milk in PBS-T (0.05% Tween 20) for 1 h at room temperature. Primary antibodies, included Bid(1:1000), caspase-3 (1:1000), caspase-8 (1:1000), caspase-9 (1:1000), anti β -actin (1:5000), Bax (1:1000) Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA), Bcl-xL (1:1000), Bcl-2 (1:1000), p53 (:1000) (Abcam Inc., Cambridge. MA, USA). Secondary antibodies conjugated to horseradish peroxidase were obtained from Kirkegaard & Perry Laboratories Inc. (Gaithersburg, MD, USA). Protein-antibody complexes were detected using Amersham ECL prime Western blotting detection reagent (GE Healthcare, Munich, Germany). Acute toxicity. The acute toxicity study was conducted according to the OECD protocol 50 . Twelve SD female rats were used for the acute toxicity study to evaluate the toxicity of PCC. All experimental protocols were approved by the ethics committee of the Faculty of Medicine, University of Malaya, Malaysia (Ethics reference no. 2015-180804/PHAR/R/BH). The methods were carried out in accordance with the National Academy of Science's Guide for the Care and Use of Laboratory Animals 51 . Two groups of animals was considered: the normal control group, which received only vehicle (5 ml/kg of 10% Tween-20), and the treated groups, which received a 200 mg/kg of PCC 52 . Prior to the experiment, all mice were fasted for 24 hours. After treatment, the animals were observed for the first 30 minutes and 4-5 times at intervals of 48 hours to discern any signs of abnormality. After 14 days, the animals were sacrificed by an overdose of xylazine and ketamine anesthesia. Blood samples were then collected for serum biochemical examination. In addition, kidney and liver histological analysis was performed using hematoxylin and eosin staining. All values are means of three experiments.
Statistical Analysis. All values are expressed as mean ± S.D. Student's t-test was used for statistical evaluation of data. A probability value of *p < 0.05 was considered statistically significant.